IDEXX Laboratories Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	180.07	288.27	453.93	112.55	144.45
Cash & Short-Term Investments	180.07	288.27	453.93	112.55	144.45
Cash Growth	-37.53%	-36.50%	303.33%	-22.09%	-62.38%
Accounts Receivable	552.38	534.33	512.56	442.47	406.12
Other Receivables	-	26.99	16.97	48.43	19.46
Receivables	552.38	561.32	529.53	490.9	425.58
Inventory	377.76	381.88	380.28	367.82	269.03
Prepaid Expenses	-	58.63	48.37	41.74	42
Other Current Assets	303.62	109.81	83.14	88.46	74.59
Total Current Assets	1,414	1,400	1,495	1,101	955.66
Property, Plant & Equipment	747.38	829.25	817.68	768.09	692.77
Long-Term Investments	-	31	30.25	30.25	5.25
Goodwill	-	405.1	365.96	361.8	359.35
Other Intangible Assets	-	111.68	84.5	97.67	99.04
Long-Term Accounts Receivable	-	185.51	167.96	148.97	122.16
Long-Term Deferred Tax Assets	-	125.63	107.36	55.22	24.78
Long-Term Deferred Charges	-	-	-	-	122.41
Other Long-Term Assets	1,190	205.38	190.96	183.29	55.8
Total Assets	3,351	3,293	3,260	2,747	2,437
Accounts Payable	110.41	114.21	110.64	110.22	116.14
Accrued Expenses	530.15	418.33	372.36	364.69	395.77
Short-Term Debt	398	250	250	579	73.5
Current Portion of Long-Term Debt	75	167.79	75	74.98	75
Current Portion of Leases	-	21.54	19.8	20.43	19.93
Current Income Taxes Payable	-	62.25	86.55	48.55	42.61
Current Unearned Revenue	35.26	33.8	37.2	37.94	40.03
Other Current Liabilities	-	-	-	-	0.6
Total Current Liabilities	1,149	1,068	951.55	1,236	763.58
Long-Term Debt	374.84	449.79	622.88	694.39	775.21
Long-Term Leases	-	97.84	99.67	101.24	87.38
Long-Term Unearned Revenue	-	26.94	28.53	30.86	41.17
Long-Term Deferred Tax Liabilities	-	11.31	7.24	8.15	8.94
Other Long-Term Liabilities	221.72	44.34	65.53	67.59	70.94
Total Liabilities	1,745	1,698	1,775	2,138	1,747
Common Stock	1,605	10.78	10.75	10.72	10.69
Additional Paid-In Capital	-	1,674	1,570	1,463	1,377
Retained Earnings	-	5,332	4,445	3,600	2,920
Treasury Stock	-	-5,334	-4,475	-4,392	-3,571
Comprehensive Income & Other	-	-87.76	-65.68	-72.61	-47.77
Total Common Equity	1,605	1,595	1,485	608.74	689.99
Shareholders' Equity	1,605	1,595	1,485	608.74	689.99
Total Liabilities & Equity	3,351	3,293	3,260	2,747	2,437
Total Debt	847.84	986.95	1,067	1,470	1,031
Net Cash (Debt)	-667.77	-698.68	-613.42	-1,357	-886.56
Net Cash Per Share	-8.24	-8.39	-7.30	-16.05	-10.24
Filing Date Shares Outstanding	79.9	81.33	83.09	82.9	84.25
Total Common Shares Outstanding	79.9	81.6	83.03	82.89	84.56
Working Capital	265.01	331.98	543.71	-134.33	192.08
Book Value Per Share	20.09	19.55	17.88	7.34	8.16
Tangible Book Value	1,605	1,079	1,034	149.27	231.61
Tangible Book Value Per Share	20.09	13.22	12.45	1.80	2.74
Land	-	23.99	22.4	22.22	22.64
Buildings	-	446.16	432.04	356.05	329.09
Machinery	-	891	837.15	772.56	728.74
Construction In Progress	-	67.14	79.06	97.31	62.34
Leasehold Improvements	-	119.84	116.35	107.25	93.25

Source: S&P Global Market Intelligence. Standard template. Financial Sources.